bioethics: Case Discussion - Double Standard for an AIDS Drug

[nipuna@stmail.lk]

> >dear all
> >
> >This case brings out important ethical issues of international
> >collaborations.
> >
> >1. Why they choose south African country to do a "rough comparison of
> >efficacy" and to take quick and dirty first look
> >
> >Will any of the euro-American countries refuse such a study to be conducted
> >in their country
> >why did not they do it in France
> >AIDS is not a tropical illness only
> >will these institutions would show the same enthusiasm for developing drugs
> >for dengue and malaria
> >
> >Developed countries should not do any clinical trials in the developing
> >world exclusively for diseases that are common to both worlds. It only
> >appears just if they do it simultaneously in both worlds or replicate a
> >trial done in developed world.
> >
> >The case and the questions seems eurocentric as the main epistemological
> >foundations of the bioethics
> >
> >sisira
> >Dr Sisira Siribaddana
> >Endocrinologist
> >Researcher
> >Sri lankan Twin Registry
> >Coordinator
> >Bio-ethics Initiative
> >Forum for Research & Development
> >Dedicated to build research capacity in Sri Lanka
> >www.forumforresearch.org
> >
> >
> >
> >-


*****
Susie Welty
Program Manager
Program on Ethical Issues in International Health Research
Department of Population and International Health
Building I -- Room 1104
Harvard School of Public Health
665 Huntington Avenue
Boston, MA  02115

Telephone:      617-432-3998
Fax:            617-566-0365
E-mail: swelty@hsph.harvard.edu
Website:        http://www.hsph.harvard.edu/bioethics